No paralogue variants have been mapped to residue 131 for KCNQ1.
KCNQ1 | ----VQGRVYNFLERPT-GWKCFVYHFAVF>L<IVLVCLIFSVLSTIEQYA------------ | 149 |
KCNQ2 | ----LQNFLYNVLERPR-G-WAFIYHAYVF>L<LVFSCLVLSVFSTIKEYE------------ | 119 |
KCNQ3 | ----IQTLIYDALERPR-G-WALLYHALVF>L<IVLGCLILAVLTTFKEYE------------ | 149 |
KCNQ4 | ----LQNWVYNVLERPR-G-WAFVYHVFIF>L<LVFSCLVLSVLSTIQEHQ------------ | 125 |
KCNQ5 | ----VQNYLYNVLERPR-G-WAFIYHAFVF>L<LVFGCLILSVFSTIPEHT------------ | 153 |
KCNA1 | -EKEYQRQVWLLFEYPESSGPARVIAIVSV>M<VILISIVIFCLETLPELKDDK-DF------ | 198 |
KCNA10 | -TNDIHRQFWLLFEYPESSSAARAVAVVSV>L<VVVISITIFCLETLPEFREDR-EL------ | 247 |
KCNA2 | -ENEFQRQVWLLFEYPESSGPARIIAIVSV>M<VILISIVSFCLETLPIFRDEN-ED------ | 194 |
KCNA3 | -RRDFQRQVWLLFEYPESSGPARGIAIVSV>L<VILISIVIFCLETLPEFRDEK-DY------ | 265 |
KCNA4 | -ENEFKKQIWLLFEYPESSSPARGIAIVSV>L<VILISIVIFCLETLPEFRDDR-DL------ | 338 |
KCNA5 | -RNEFQRQVWLIFEYPESSGSARAIAIVSV>L<VILISIITFCLETLPEFRDER-ELLRHPPA | 287 |
KCNA6 | -SQPFQRQVWLLFEYPESSGPARGIAIVSV>L<VILISIVIFCLETLPQFRVDG-RGGNNGGV | 211 |
KCNA7 | -RRAFARQLWLLFEFPESSQAARVLAVVSV>L<VILVSIVVFCLETLPDFRDDR-DGTGL--- | 177 |
KCNB1 | -CAEKRKKLWDLLEKPNSSVAAKILAIISI>M<FIVLSTIALSLNTLPELQSLD-EF------ | 220 |
KCNB2 | -CPDKRKKLWDLLEKPNSSVAAKILAIVSI>L<FIVLSTIALSLNTLPELQETD-EF------ | 224 |
KCNC1 | -WRRWQPRIWALFEDPYSSRYARYVAFASL>F<FILVSITTFCLETHERFNPIV-NK------ | 221 |
KCNC2 | -WRRLQPRMWALFEDPYSSRAARFIAFASL>F<FILVSITTFCLETHEAFNI---VK------ | 258 |
KCNC3 | -WRRWQPRVWALFEDPYSSRAARYVAFASL>F<FILISITTFCLETHEGFIHIS-NK------ | 321 |
KCNC4 | -CRGWQPRMWALFEDPYSSRAARVVAFASL>F<FILVSITTFCLETHEAFNI---DR-NV--- | 257 |
KCND1 | AGSSLRQRLWRAFENPHTSTAALVFYYVTG>F<FIAVSVIANVVETIPCRGSAR-RS------ | 217 |
KCND2 | TMT-ARQRVWRAFENPHTSTMALVFYYVTG>F<FIAVSVIANVVETVPCGS-SP-GH------ | 215 |
KCND3 | SLS-FRQTMWRAFENPHTSTLALVFYYVTG>F<FIAVSVITNVVETVPCGT-VP-G------- | 212 |
KCNF1 | -WRRCQKCVWKFLEKPESSCPARVVAVLSF>L<LILVSSVVMCMGTIPELQVLD-AE------ | 213 |
KCNG1 | -GR-CMRRLRDMVERPHSGLPGKVFACLSV>L<FVTVTAVNLSVSTLPSLREEEE-Q------ | 258 |
KCNG2 | -QR-GRRRLRDVVDNPHSGLAGKLFACVSV>S<FVAVTAVGLCLSTMPDIRAEEE-R------ | 208 |
KCNG3 | -SRRWLERMRRTFEEPTSSLAAQILASVSV>V<FVIVSMVVLCASTLPDWRN-AAAD------ | 202 |
KCNG4 | -GL-CMNRLREMVENPQSGLPGKVFACLSI>L<FVATTAVSLCVSTMPDLRAEED-Q------ | 252 |
KCNS1 | -CGRLRRRLWLTMENPGYSLPSKLFSCVSI>S<VVLASIAAMCIHSLPEYQARE-AA------ | 251 |
KCNS2 | -LGNFRRQLWLALDNPGYSVLSRVFSILSI>L<VVMGSIITMCLNSLPDFQIPD-SQ------ | 218 |
KCNS3 | -FGQLRKKIWIRMENPAYCLSAKLIAISSL>S<VVLASIVAMCVHSMSEFQNED-GE------ | 216 |
KCNV1 | -CPTVRQKLWNILEKPGSSTAARIFGVISI>I<FVVVSIINMALMSAEL-------------- | 234 |
KCNV2 | -YGPQRRRLWNLMEKPFSSVAAKAIGVASS>T<FVLVSVVALALNTVEEMQQHS-GQ------ | 291 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.Leu131Pro | c.392T>C | Unknown | SIFT: Polyphen: |